![](/img/cover-not-exists.png)
The novel mTORC1/2 inhibitor PQR620 has in vitro and in vivo activity in lymphomas
Tarantelli, C., Gaudio, E., Hillmann, P., Spriano, F., Rinaldi, A., Kwee, I., Cascione, L., Fabbro, D., Stathis, A., Zucca, E., Cmiljanovic, V., Bertoni, F.Volume:
69
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(16)32696-X
Date:
December, 2016
File:
PDF, 51 KB
english, 2016